Huayuan Zhiyin Overview
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
1
Huayuan Zhiyin General Information
Description
Developer of cellular drug disorder application tools designed for human drug efficacy prediction. The company provides an integrated single-cell multiomics analysis system and multimodal fusion algorithms to capture DNA, transcriptome, and proteome data, enabling pharmaceutical companies to assess drug efficacy and toxicity risks through cellular perturbation tracking and clinical human tumor cohort data integration.
Contact Information
Corporate Office
- China
Corporate Office
- China
Huayuan Zhiyin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 07-Jul-2026 | Completed | Startup |
Huayuan Zhiyin Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Tsinghua Innovation Ventures | Venture Capital | Minority |
Huayuan Zhiyin FAQs
-
Where is Huayuan Zhiyin headquartered?
Huayuan Zhiyin is headquartered in China.
-
What industry is Huayuan Zhiyin in?
Huayuan Zhiyin’s primary industry is Biotechnology.
-
Is Huayuan Zhiyin a private or public company?
Huayuan Zhiyin is a Private company.
-
What is Huayuan Zhiyin’s current revenue?
The current revenue for Huayuan Zhiyin is .
-
Who are Huayuan Zhiyin’s investors?
Tsinghua Innovation Ventures has invested in Huayuan Zhiyin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process